Hepsera

In the US, Hepsera (adefovir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B.

US matches:

• Hepsera

UK matches:

• Hepsera 10 mg tablets (SPC)

Ingredient matches for Hepsera

Adefovir

Adefovir dipivoxil (a derivative of Adefovir) is reported as an ingredient of Hepsera in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Brazil


• Canada


• Chile


• China


• Colombia


• Costa Rica


• Cyprus


• Czech Republic


• Denmark


• Dominican Republic


• El Salvador


• Finland


• France


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Panama


• Peru


• Philippines


• Poland


• Singapore


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Turkey


• United Kingdom


• United States


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.